Antibody-Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases

被引:1
作者
Bian, David J. H. [1 ]
Cohen, Sara F. [2 ]
Lazaratos, Anna-Maria [3 ,4 ]
Bouganim, Nathaniel [5 ]
Dankner, Matthew [1 ,4 ]
机构
[1] McGill Univ, Fac Med & Hlth Sci, Dept Internal Med, Montreal, PQ H3A 1G1, Canada
[2] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1G1, Canada
[3] Univ Montreal, Fac Med, Montreal, PQ H3A 1G1, Canada
[4] McGill Univ, Rosalind & Morris Goodman Canc Inst, Montreal, PQ H3A 1G1, Canada
[5] McGill Univ Hlth Ctr, Dept Oncol, Montreal, PQ H4A 3J1, Canada
关键词
brain metastasis; central nervous system metastasis; non-small-cell lung cancer; lung cancer; antibody-drug conjugate; ADC; BRAIN METASTASES; BREAST-CANCER; TRASTUZUMAB EMTANSINE; OPEN-LABEL; C-MET; PHASE-II; SACITUZUMAB GOVITECAN; SINGLE-ARM; ADVANCED NSCLC; HER2; MUTATION;
D O I
10.3390/curroncol31100471
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Antibody-drug conjugates (ADCs) represent an emerging class of targeted anticancer agents that have demonstrated impressive efficacy in numerous cancer types. In non-small cell lung cancer (NSCLC), ADCs have become a component of the treatment armamentarium for a subset of patients with metastatic disease. Emerging data suggest that some ADCs exhibit impressive activity even in central nervous system (CNS) metastases, a disease site that is difficult to treat and associated with poor prognosis. Herein, we describe and summarize the existing evidence surrounding ADCs in NSCLC with a focus on CNS activity.
引用
收藏
页码:6314 / 6342
页数:29
相关论文
共 147 条
[1]   Brain metastases [J].
Achrol, Achal Singh ;
Rennert, Robert C. ;
Anders, Carey ;
Soffietti, Riccardo ;
Ahluwalia, Manmeet S. ;
Nayak, Lakshmi ;
Peters, Solange ;
Arvold, Nils D. ;
Harsh, Griffith R. ;
Steeg, Patricia S. ;
Chang, Steven D. .
NATURE REVIEWS DISEASE PRIMERS, 2019, 5 (1)
[2]   Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity [J].
Ackerman, Shelley E. ;
Pearson, Cecelia I. ;
Gregorio, Joshua D. ;
Gonzalez, Joseph C. ;
Kenkel, Justin A. ;
Hartmann, Felix J. ;
Luo, Angela ;
Ho, Po Y. ;
LeBlanc, Heidi ;
Blum, Lisa K. ;
Kimmey, Samuel C. ;
Luo, Andrew ;
Nguyen, Murray L. ;
Paik, Jason C. ;
Sheu, Lauren Y. ;
Ackerman, Benjamin ;
Lee, Arthur ;
Li, Hai ;
Melrose, Jennifer ;
Laura, Richard P. ;
Ramani, Vishnu C. ;
Henning, Karla A. ;
Jackson, David Y. ;
Safina, Brian S. ;
Yonehiro, Grant ;
Devens, Bruce H. ;
Carmi, Yaron ;
Chapin, Steven J. ;
Bendall, Sean C. ;
Kowanetz, Marcin ;
Dornan, David ;
Engleman, Edgar G. ;
Alonso, Michael N. .
NATURE CANCER, 2021, 2 (01) :18-+
[3]   Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing [J].
Ahn, Beung-Chul ;
Han, Ye-Jeong ;
Kim, Hye Ryun ;
Hong, Min Hee ;
Cho, Byoung Chul ;
Lim, Sun Min .
CANCER RESEARCH AND TREATMENT, 2023, 55 (02) :488-497
[4]   Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study [J].
Ahn, Myung-Ju ;
Tanaka, Kentaro ;
Paz-Ares, Luis ;
Cornelissen, Robin ;
Girard, Nicolas ;
Pons-Tostivint, Elvire ;
Vicente Baz, David ;
Sugawara, Shunichi ;
Cobo, Manuel ;
Perol, Maurice ;
Mascaux, Celine ;
Poddubskaya, Elena ;
Kitazono, Satoru ;
Hayashi, Hidetoshi ;
Hong, Min Hee ;
Felip, Enriqueta ;
Hall, Richard ;
Juan-Vidal, Oscar ;
Brungs, Daniel ;
Lu, Shun ;
Garassino, Marina ;
Chargualaf, Michael ;
Zhang, Yong ;
Howarth, Paul ;
Uema, Deise ;
Lisberg, Aaron ;
Sands, Jacob .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (03) :260-272
[5]   The blood-brain barrier and blood-tumour barrier in brain tumours and metastases [J].
Arvanitis, Costas D. ;
Ferraro, Gino B. ;
Jain, Rakesh K. .
NATURE REVIEWS CANCER, 2020, 20 (01) :26-41
[6]   Antibody-Drug Conjugates-A Tutorial Review [J].
Baah, Stephanie ;
Laws, Mark ;
Rahman, Khondaker Miraz .
MOLECULES, 2021, 26 (10)
[7]   Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trial [J].
Balinda, Henriette U. ;
Kelly, William J. ;
Kaklamani, Virginia G. ;
Lathrop, Kate I. ;
Canola, Marcela Mazo ;
Ghamasaee, Pegah ;
Sareddy, Gangadhara R. ;
Michalek, Joel ;
Gilbert, Andrea R. ;
Surapaneni, Prathibha ;
Tiziani, Stefano ;
Pandey, Renu ;
Chiou, Jennifer ;
Lodi, Alessia ;
Floyd, John R. ;
Brenner, Andrew J. .
NATURE COMMUNICATIONS, 2024, 15 (01)
[8]   Prevalence, molecular characterization, and prognosis of METeoverexpressing non-small cell lung cancer (NSCLC) in a real-world patient cohort [J].
Bar, J. ;
Cai, M. H. ;
Choi, Y. C. ;
Baijal, S. ;
Zhao, W. ;
Liede, A. ;
Raskin, L. ;
Vasilopoulos, A. ;
Li, M. ;
Roberts-Rapp, L. ;
Jiang, F. ;
Ratajczak, C. ;
Lu, S. ;
Ansell, P. J. ;
Camidge, D. R. .
ANNALS OF ONCOLOGY, 2023, 34
[9]   Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer [J].
Bardia, A. ;
Hurvitz, S. A. ;
Tolaney, S. M. ;
Loirat, D. ;
Punie, K. ;
Oliveira, M. ;
Brufsky, A. ;
Sardesai, S. D. ;
Kalinsky, K. ;
Zelnak, A. B. ;
Weaver, R. ;
Traina, T. ;
Dalenc, F. ;
Aftimos, P. ;
Lynce, F. ;
Diab, S. ;
Cortes, J. ;
O'Shaughnessy, J. ;
Dieras, V ;
Ferrario, C. ;
Schmid, P. ;
Carey, L. A. ;
Gianni, L. ;
Piccart, M. J. ;
Loibl, S. ;
Goldenberg, D. M. ;
Hong, Q. ;
Olivo, M. S. ;
Itri, L. M. ;
Rugo, H. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) :1529-1541
[10]   Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression [J].
Bardia, Aditya ;
Rugo, Hope S. ;
Tolaney, Sara M. ;
Loirat, Delphine ;
Punie, Kevin ;
Oliveira, Mafalda ;
Brufsky, Adam ;
Kalinsky, Kevin ;
Cortes, Javier ;
O'Shaughnessy, Joyce ;
Dieras, Veronique ;
Carey, Lisa A. ;
Gianni, Luca ;
Piccart-Gebhart, Martine ;
Loibl, Sibylle ;
Yoon, Oh Kyu ;
Pan, Yang ;
Hofsess, Scott ;
Phan, See-Chun ;
Hurvitz, Sara A. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (15) :1738-1744